Mycophenolate mofetil for treatment of ongoing or chronic rejections after liver transplantation

Transplant Proc. 2002 Nov;34(7):2938-9. doi: 10.1016/s0041-1345(02)03496-6.

Authors

R Pfitzmann¹, J Klupp, J M Langrehr, R Neuhaus, G Junge, U Settmacher, T Steinmüller, P Neuhaus

Affiliation

¹ Department of Surgery, Charité, Virchow-Klinikum, Humboldt-University Berlin, Berlin, Germany.

PMID: 12431665
DOI: 10.1016/s0041-1345(02)03496-6

No abstract available

MeSH terms

Administration, Oral
Chronic Disease
Drug Administration Schedule
Drug Therapy, Combination
Graft Rejection / drug therapy*
Humans
Liver Transplantation / immunology*
Muromonab-CD3 / administration & dosage
Muromonab-CD3 / therapeutic use
Mycophenolic Acid / administration & dosage
Mycophenolic Acid / analogs & derivatives
Mycophenolic Acid / therapeutic use*
Postoperative Period
Prednisolone / administration & dosage
Prednisolone / therapeutic use
Retrospective Studies

Substances

Muromonab-CD3
Prednisolone
Mycophenolic Acid